Palisade Bio (PALI) Other Operating Expenses (2010 - 2026)
Palisade Bio (PALI) reported Other Operating Expenses of -$3.8 million for Q1 2026, down 183.67% year-over-year from $4.6 million in Q1 2025, and down 7.03% on a QoQ basis from -$3.6 million in Q4 2025.
Palisade Bio (PALI) has 10 years of Other Operating Expenses data on file, last reported at -$3.8 million in Q1 2026.
- Quarterly Other Operating Expenses fell 183.67% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.1 million (up 47.94% YoY) and the FY2025 annual result came in at -$7.6 million, down 38.37% from the prior year.
- Other Operating Expenses retreated to -$3.8 million in Q1 2026 per PALI's latest filing, from -$3.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $1.2 million in Q4 2023 and bottomed at -$15.1 million in Q3 2024.
- The 5-year median for Other Operating Expenses is -$1.4 million (2024), against an average of -$2.6 million.
- The widest annual swing landed in 2024, when Other Operating Expenses tumbled 212.07%; it then soared 89.94% in 2025.
- Tracing PALI's Other Operating Expenses over 5 years: stood at $410000.0 in 2022, then jumped by 200.98% to $1.2 million in 2023, then plunged by 212.07% to -$1.4 million in 2024, then tumbled by 158.13% to -$3.6 million in 2025, then fell by 7.03% to -$3.8 million in 2026.
- Per Business Quant, the three latest PALI Other Operating Expenses figures stand at -$3.8 million (Q1 2026), -$3.6 million (Q4 2025), and -$1.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -3.57 Mn |
| Sep 30, 2025 | -1.52 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | -1.38 Mn |
| Sep 30, 2024 | -15.10 Mn |
| Jun 30, 2024 | -1.48 Mn |
| Mar 31, 2024 | -1.38 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2022 | 410,000.00 |
| Jun 30, 2021 | 30.12 Mn |
| Dec 31, 2013 | 171.00 |
| Sep 30, 2013 | 293.00 |
| Jun 30, 2013 | 50,636.00 |
| Mar 31, 2013 | 50,093.00 |
| Dec 31, 2012 | 219.00 |
| Sep 30, 2012 | 692.00 |
| Mar 31, 2012 | 2,573.00 |
| Mar 31, 2011 | 250,000.00 |
| Dec 31, 2010 | 28,755.00 |
| Sep 30, 2010 | 42,333.00 |
| Jun 30, 2010 | 30,601.00 |